Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial BLOOD Shanafelt, T. D., Wang, X., Hanson, C. A., Paietta, E. M., O'Brien, S., Barrientos, J., Jelinek, D. F., Braggio, E., Leis, J. F., Zhang, C., Coutre, S. E., Barr, P. M., Cashen, A. F., Mato, A. R., Singh, A. K., Mullane, M. P., Little, R. F., Erba, H., Stone, R. M., Litzow, M., Tallman, M., Kay, N. E. 2022; 140 (2): 112-120

View details for Web of Science ID 000850303000007